The following article, New COVID Pill Shows Promise in Reducing Death and Hospitalization, was first published on Flag And Cross.
While a vast majority of our nation continues to bicker over the efficacy and legality of the COVID-19 vaccine mandates that continue to be implemented, a new treatment for those afflicted with coronavirus could change the way that our nation handles the deadly disease.
While a vast majority of healthy Americans who contact a COVID infection will recover without much help, there are varying underlying conditions that make the possibility of a severe infection possible in otherwise fit folks. That’s why it is still rather important for our health professionals to explore treatment options for COVID and not just the purportedly preventative vaccines.
The latest treatment hope may be the simplest yet.
In a potential leap forward in the global fight against the pandemic, drugmaker Merck said Friday that its experimental pill for people sick with COVID-19 reduced hospitalizations and deaths by half.
That could add a whole new, easy-to-use weapon to an arsenal that already includes the COVID-19 vaccine.
The company said it will soon ask health officials in the U.S. and around the world to authorize the pill’s use. A decision from the U.S. Food and Drug Administration could come within weeks after that, and the drug, if it gets the OK, could be distributed quickly soon afterward.
Treatment in a pill form would not only make it much simpler for Americans to receive the attention that they need, but it would also be far less expensive.
This cost-cutting would extend from the patient to the facility and beyond, as home treatment would help to free up a vast number of hospital beds and other resources.
Continue reading: New COVID Pill Shows Promise in Reducing Death and Hospitalization ...